Home › Funds › ALKEME WEALTH, LLC › CVS

ALKEME WEALTH, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

ALKEME WEALTH, LLC reported holding 32,415 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 1.05% of its reported portfolio and ranking #35 among its reported holdings. ALKEME WEALTH, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)32.41K sh
Reported value held$2.78M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ALKEME WEALTH, LLC's CVS position evolved

ALKEME WEALTH, LLC first disclosed a stake in CVS in Q3 2023 at 31,699 shares (US$2.2M). The position peaked in Q2 2026 at 34,983 shares, worth US$3.6M. Across 13 filings, ALKEME WEALTH, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 32,415 shares valued at US$2.8M — a reduction of -2,568 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2024 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 31.70K $2.21M New
Q4 2023 32.70K $2.63M Add
Q1 2024 32.92K $2.43M Add
Q2 2024 44.52K $2.63M Add
Q3 2024 45.56K $2.87M Add
Q4 2024 40.04K $1.80M Reduce
Q1 2025 42.07K $2.85M Add
Q2 2025 39.19K $2.70M Reduce
Q3 2025 38.78K $2.92M Reduce
Q4 2025 37.62K $2.99M Reduce
Q1 2026 37.58K $2.70M Hold
Q2 2026 34.98K $3.62M Reduce
Q3 2026 32.41K $2.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has ALKEME WEALTH, LLC held CVS?

ALKEME WEALTH, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ALKEME WEALTH, LLC's current position in CVS?

As of Q3 2026, ALKEME WEALTH, LLC holds 32.41K shares of CVS (CVS HEALTH CORP), valued at $2.78M, representing 1.05% of its reported portfolio and ranking #35.

Has ALKEME WEALTH, LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), ALKEME WEALTH, LLC reduced its position in CVS. The position peaked in Q2 2026 at 34.98K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.